Nutritional genomic approaches to cancer prevention research

Experimental Oncology

Volumn 29, Issue 4, 2007, Pages 250-256

  Ross, S A ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Epigenetics; Gene expression; Nutrigenetics; Nutrition

Indexed keywords

HISTONE;

CANCER RESEARCH; CHROMATIN; DIET; DNA METHYLATION; EPIGENETICS; FOOD COMPOSITION; GENE EXPRESSION; GENETIC VARIABILITY; NUTRIENT; NUTRIGENOMICS; PROTEIN PROCESSING; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM;

ANIMALS; EPIGENESIS, GENETIC; GENE EXPRESSION; GENE EXPRESSION REGULATION, NEOPLASTIC; GENOMICS; HUMANS; NEOPLASMS; NUTRITION THERAPY;

EID: 39049156783     PISSN: 18129269     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (53)

1. World Cancer Research Fund / American Institute for Cancer Research. Food, Nutrition and the Prevention of Cancer: a Global Perspective. Washington DC: AICR, 1997. (http://www.aicr.org/site/PageServer?pagename=res_report_home).
2. World Cancer Research Fund / American Institute for Cancer Research. Food, Nutrition, Physical Activity, and the Prevention of Cancer: a Global Perspective. Washington DC: AICR, 2007. http://www.aicr.org/site/PageServer? pagename=res_report_second
3. Manson MM, Foreman, BE, Howells LM, et al. Determining the efficacy of dietary phytochemicals in cancer prevention. Biochem Soc Trans 2007; 35: 1358-6.
4. Bhattacharya A, Banu J, Rahman M, et al. Biological effects of conjugated linoleic acids in health and disease. J Nutr Biochem 2006; 17: 789-810.
5. Simopoulos AP. Evolutionary aspects of diet, the omega-6/omega-3 ratio and genetic variation: nutritional implications for chronic diseases. Biomed Pharmacother 2006; 60: 502-27.
6. Chen S, Oh SR, Phung S, et al. Anti-aromatase activity of phytochemicals in white button mushrooms (Agaricus bisporus). Cancer Res 2006; 66: 12026-34.
7. Wollowski I, Rechkemmer G, Pool-Zobel BL. Protective role of probiotics and prebiotics in colon cancer. Am J Clin Nutr 2001; 73: 451S-5S.
8. Davis CD, Milner JA. Molecular targets for nutritional preemption of cancer. Curr Cancer Drug Targets 2007; 7: 410-5.
9. Pierce JP, Natarajan L, Caan BJ, et al. Influence of a diet very high in vegetables, fruit and fiber and low in fat on prognosis following treatment for breast cancer: the Women's Healthy Eating and Living (WHEL) randomized trial. JAMA 2007; 298: 289-98.
10. Lampe JW, Chang JL. Interindividual differences in phytochemical metabolism and disposition. Semin Cancer Biol 2007; 17: 347-53.
11. Wooding S, Kim UK, Bamshad MJ, et al. Natural selection and molecular evolution in PTC, a bitter-taste receptor gene. Am J Hum Genet 2004; 74: 637-46.
12. Clement K. Genetics of human obesity. Proc Nutr Soc 2005; 64: 133-42.
13. Davis CD, Milner J. Frontiers in nutrigenomics, proteomics, metabolomics and cancer prevention. Mutat Res 2004; 551: 51-64.
14. Trujillo E, Davis C, Milner J. Nutrigenomics, proteomics, metabolomics, and the practice of dietetics. J Am Diet Assoc 2006; 106: 403-13.
15. Holick MF. Vitamin D: it's role in cancer prevention and treatment. Prog Piophys Mol Biol 2006; 52: 49-59.
16. Rukin NJ, Strange RC. What are the frequency, distribution, and functional effects of vitamin D receptor polymorphisms as related to cancer risk? Nutr Rev 2007; 65: S96-101.
17. Ingles SA. Can diet and/or sunlight modify the relationship between vitamin D receptor polymorphisms and prostate cancer risk? Nutr Rev 2007; 65: S105-7.
18. Wong HL, Seow A, Arakawa K, et al. Vitamin D receptor start codon polymorphism and colorectal cancer risk: Effect modification by dietary calcium and fat in Singapore Chinese. Carcinogenesis 2003; 24: 1091-5.
19. Davis CD, Hartmuller V, Freedman DM, et al. Vitamin D and cancer: current dilemmas and future needs. Nutr Rev 2007; 65: S71-4.
20. Slattery ML, Neuahusen SL, Hoffman M, et al. Dietary calcium, vitamin D, VDR genotypes and colorectal cancer. Int J Cancer 2004; 111: 750-6.
21. Redon R, Ishikawa S, Fitch KR, et al. Global variation in copy number in the human genome. Nature 2006; 444: 444-54.
22. Ambrosone CB, Freudenheim JL, Thompson PA, et al. Manganese superoxide dismutase (MnSOD) genetic polymorphisms, dietary antioxidants, and risk of breast cancer. Cancer Res 1999; 59: 602-6.
23. Li H, Kantoff PW, Giovannucci E, et al. Manganese superoxide dismutase polymorphism, prediagnostic antioxidant status, and risk of clinical significant prostate cancer. Cancer Res 2005; 65: 2498-504.
24. Küry S, Buecher B, Robiou-du-Pont S, et al. Combinations of cytochrome P450 gene polymorphisms enhancing the risk for sporadic colorectal cancer related to red meat consumption. Cancer Epidemiol Biomarkers Prev 2007; 16: 1460-7.
25. Ulrich CM, Curtin K, Potter JD, et al. Polymorphisms in the reduced folate carrier, thymidylate synthase, or methionine synthase and risk of colon cancer. Cancer Epidemiol Biomarkers Prev 2005; 14: 2509-16.
26. Whitfield GK, Remus LS, Jurutka PW, et al. Functionally relevant polymorphisms in the human nuclear vitamin D receptor gene. Mol Cell Endocrinol 2001; 177: 145-59.
27. Jirtle RL, Skinner MK. Environmental epigenomics and disease susceptibility. Nat Rev Genet 2007; 8: 253-62.
28. Esteller M. The necessity of a human epigenome project. Carcinogenesis 2006; 27: 1121-5.
29. Ross SA. Diet and DNA methylation interactions in cancer prevention. Ann N Y Acad Sci 2003; 983: 197-207.
30. Park SY, Kim BH, Kim JH, et al. Methylation profiles of CpG island loci in major types of human cancers. J Korean Med Sci 2007; 22: 311-7.
31. Wilson AS, Power BE, Molloy PL. DNA hypomethylation and human diseases. Biochim Biophys Acta 2007; 1775: 138-62.
32. Esteller M. Epigenetic gene silencing in cancer: the DNA hypermethylome. Hum Mol Genet 2007; 16: R50-9.
33. Fraga MF, Ballestar E, Villar-Garea A, et al. Loss of acetylation at Lys16 and trimethylation at Lys20 ofhistone H4 is a common hallmark of human cancer. Nat Genet 2005; 37: 391-400.
34. Rosato RR, Grant S. Histone deacetylase inhibitors in cancer therapy. Cancer Biol Ther 2003; 2: 30-7.
35. Matzke MA, Birchler JA. RNAi-mediated pathways in the nucleus. Nat Rev Genet 2005; 6: 24-35.
36. Chuang JC, Jones PA. Pediatr Res Epigenetics and microRNAs 2007; 61: 24R-29R.
37. Poirier LA. Methyl group deficiency in hepatocarcinogenesis. Drug Metab Rev 1994; 26: 185-99.
38. Wolff GL, Kodell RL, Moore SR, et al. Maternal epigenetics and methyl supplements affect agouti gene expression in Avy/a mice. FASEB J 1998; 12: 949-57.
39. Waterland RA, Jirtle RL. Transposable elements: targets for early nutritional effects on epigenetic gene regulation. Mol Cell Biol 2003; 23: 5293-300.
40. Dolinoy DC, Weidman JR, Waterland RA, et al. Maternal genistein alters coat color and protects Avy mouse offspring from obesity by modifying the fetal epigenome. Environ Health Perspect 2006; 114: 567-72.
41. Dolinoy DC, Huang D, Jirtle RL. Maternal nutrient supplementation counteracts bisphenol A-induced DNA hypomethylation in early development. Proc Natl Acad Sci USA 2007; 104: 13056-61.
42. Davis CD, Ross SA. Dietary components impact histone modifications and cancer risk. Nutr Rev 2007; 65: 88-94.
43. Myzak MC, Hardin K, Wang R, et al. Sulforaphane inhibits histone deacetylase activity in BPH-1, LnCaP and PC-3 prostate epithelial cells. Carcinogenesis 2006; 27: 811-9.
44. Myzak MC, Karplus PA, Chung FL, et al. A novel mechanism of chemoprotection by sulforaphane: inhibition of histone deacetylase. Cancer Res 2004; 64: 5767-74.
45. Dashwood RH, Ho E. Dietary histone deacetylase inhibitors: from cells to mice to man. Semin Cancer Biol 2007; 17: 363-9.
46. Feder ME, Walser JC. The biological limitations of transcriptomics in elucidating stress and stress responses. J Evol Bio 2005; 18: 901-10.
47. Viguerie N, Poitou C, Cancello R, et al. Transcriptomics applied to obesity and caloric restriction. Biochimie 2005; 87: 117-23.
48. Gamet-Payrastre L. Signaling pathways and intracellular targets of sulforaphane mediating cell cycle arrest and apoptosis. Curr Cancer Drug Targets 2006; 6: 135-45.
49. Chen C, Pung D, Leong V, et al. Induction of detoxifying enzymes by garlic organosulfur compounds through transcription factor Nrf2: effect of chemical structure and stress signals. Free Radic Biol Med 2004; 37: 1578-90.
50. Thimmulappa RK, Mai KH, Srisuma S, et al. Identification of Nrf2-regulated genes induced by the chemopreventive agent sulforaphane by oligonucleotide microarray. Cancer Res 2002; 62: 5196-203.
51. Marks LS, Kojima M, Demarzo A, et al. Prostate cancer in native Japanese and Japanese-American men: effects of dietary differences on prostate tissue. Urology 2004; 64: 765-71.
52. van Erk MJ, Blom WA, van Ommen B, et al. High-protein and high-carbohydrate breakfasts differentially change the transcriptome of human blood cells. Am J Clin Nutr 2006; 84: 1233-41.
53. Lin DW, Neuhouser ML, Schenk JM, et al. Low-fat, low-glycemic load diet and gene expression in human prostate epithelium: a feasibility study of using cDNA microarrays to assess the response to dietary intervention in target tissues. Cancer Epidemiol Biomarkers Prev 2007; 16: 2150-4.